Table 1.
Dosimetric parameters for unilateral and bilateral hip prostate patients.
| A | B | C | D | E | |
|---|---|---|---|---|---|
| Bilateral | Rt. Lateral | Rt. Lateral | Lt. Lateral | Lt. Lateral | |
| PTV | |||||
| Max. dose (%) | 105.8 | 108.2 | 111.9 | 111.7 | 109.2 |
| D2 (cGy) | 8010.0 | 7910.0 | 7987.0 | 7951.0 | 7971.0 |
| D98 (cGy) | 7496.0 | 7549.8 | 7502.0 | 7517.0 | 7543.0 |
| Bladder | |||||
| Max. dose (%) | 105.8 | 105.6 | 107.6 | 105.5 | 104.3 |
| V70 (%) | 20.0 | 7.3 | 28.0 | 8.7 | 5.2 |
| V50 (%) | 31.1 | 14.3 | 49.7 | 13.8 | 13.1 |
| Rectum | |||||
| V50 (%) | 32.8 | 32.9 | 42.6 | 30.8 | 26.5 |
| V60 (%) | 21.4 | 24.1 | 29.3 | 19.3 | 14.6 |
| V70 (%) | 13.6 | 16.1 | 19.4 | 12.1 | 7.6 |
| V75 (%) | 9.4 | 11.7 | 12.8 | 8.5 | 5.1 |
| Rt. femur | |||||
| Mean dose (cGy) | 384.1 | 606.0 | 526.5 | 481.6 | 921.7 |
| Max. dose (cGy) | 2757.0 | 1333.0 | 3690.0 | 3472.0 | 1995.0 |
| V10 (%) | 16.1 | 0.0 | 4.6 | 5.8 | 46.0 |
| Lt. femur | |||||
| Mean dose (cGy) | 500.8 | 979.0 | 965.9 | 522.5 | 483.0 |
| Max. dose (cGy) | 1742.6 | 3254.0 | 3104.0 | 1932.0 | 973.0 |
| V10 (%) | 2.8 | 0.5 | 40.3 | 5.8 | 0.0 |